Moderate hypoglycemia days were significantly decreased in those using a hospital-managed insulin pump (3.1%) and a caregiver-managed home insulin pump (4.5%) compared with those receiving insulin injections (5.1%). This evidence concerns the gene INS and Hypoglycemia.